Biopharmaceutical Scientists specialize in the development and production of biologically-based medicines, including therapeutic proteins, antibodies, and vaccines, derived from living organisms. Their work involves understanding the molecular mechanisms of diseases and designing biologics that can interact with the body to treat or prevent them. These scientists work with complex biologic molecules, ensuring they are stable, effective, and safe for human use. From early-stage discovery to large-scale manufacturing, biopharmaceutical scientists employ advanced techniques like recombinant DNA technology, cell culture, and protein engineering to develop new treatments. Their expertise is essential in the development of innovative therapies for conditions that are difficult to treat with traditional pharmaceuticals, such as autoimmune diseases and cancer.
Biopharmaceutical scientists are also responsible for optimizing production processes and ensuring regulatory compliance. They collaborate with regulatory agencies, quality control teams, and manufacturing experts to scale up production and ensure that products meet strict safety and efficacy standards. As biologic therapies become increasingly common, these scientists are pushing the boundaries of medicine by developing personalized and targeted treatments that offer more precise and effective solutions for patients. Their research continues to be pivotal in shaping the future of healthcare, offering hope for patients with conditions that previously had limited treatment options. With the rise of biologics, biopharmaceutical scientists are at the forefront of modern medicine, driving breakthroughs that will impact global healthcare for years to come.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India